A Comparative Study of Ingudi phalamajja Lepa and Ananatmul Ghan in The Management of Vyanga (Melasma) by Wake, Shraddha et al.

International Journal of Ayurvedic Medicine, Vol 11 (2), 331-336
Published online in http://ijam.co.in 
  
ISSN No: 0976-5921
 
Research Article 
 
 
Key Words: Vyanga, Melasma, Ingudi phalmajja, Ananatmul Ghan. 
Introduction 
Now a day, the importance of Beauty and 
Personality is on the rise. In this aesthetic era, people 
are getting more and more beauty conscious, so 
everyone wants beautiful and healthy skin. Due to 
change in life style and atmosphere, dermatological 
problems are on high. Beauty of a person is assessed by 
the complexion and texture of the skin to a great extent. 
The normal color of skin in human is largely due to 
melanin pigment. Melasma is most common disorder 
which is related to melanin. It is a human 
melanogenesis dysfunction that results in localized, 
chronic acquired hypermelanosis of the skin. It occurs 
symmetrically on sun exposed areas of the body and 
affects especially female.(1)  It is accounting for 0.25 to 
4% of the patients seen in Dermatology Clinics in South 
East Asia, and is the most common pigment disorder 
among Indians.(2,3)  Although women are 
predominantly affected, men are not excluded from 
melasma, representing approximately 10% of the cases.
(4) It is rarely reported before puberty.  It can affect up 
to 50- 70% of pregnant women.(4,5,6,) Though the 
etiological factors are unknown but genetic, ethnic (skin 
type), hormonal and environmental i.e. ultraviolet (UVA 
and UVB) exposures can be called as major 
contributing factors. Many modalities of treatment are 
available, but chances of recurrence are more after 
discontinuation of the treatment or long-lasting usage of 
local preparations may produce irritation.(5,6,7) In 
Ayurveda melasma can be correlated with Vyanga which 
is described under kshudraroga because of resemblance 
of its clinical features. According to Acharya Charak, it 
is caused due to vitiation of Pitta and Shonit(8) but 
other Acharyas has depicted it due to the vitiation of 
Vāta and Pitta.(9,10,11,12,13) In Ayurvedic texts, 
various therapies like Raktamokshan, Siravedha as well 
as some medicines for internal & external use are 
mentioned.  
Need of study 
Melasma has a significant impact on 
appearance causing psychosocial distress, low self-
conf idence and decl ine in qual i ty of l i fe .
(14,15,16,17,18) Because of its increasing prevalence 
and unsatisfactory management, it is needed to discover 
some herbal preparation to overcome it.  
Aim 
Efficacy  of Ingudi Phalmajja lepa with and 
without internal use of Anantamoola Ghana in Vyanga. 
Objectives of the study 
1. To evaluate the efficacy of Ingudi phalmajja 
lepa. 
2. To evaluate the efficacy of Ingudi phalmajja 
lepa with Anantamoola ghana in vyanga. 
3. To compare the effecacy of Ingudi phalmajja 
lepa and Ingudi phalmajja lepa with 
Anantamoola ghana in vyanga. 
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Abstract
The normal color of skin in human is largely due to melanin pigment. Melasma is most common disorder 
which is related to melanin. It is a human melanogenesis dysfunction that results in localized, chronic acquired 
hypermelanosis of the skin. In Ayurveda melasma can be correlated with Vyanga because of resemblance of its 
clinical features. According to Acharya Charak, it is caused due to vitiation of Pitta and Shonita  but other Acharyas 
has depicted it due to the vitiation of Vāta and Pitta. This study is aimed to explore the Efficacy of Ingudi Phalmajja 
lepa with and without internal use of Anantamoola Ghana in Vyanga. Total 43 patients were registered and randomly 
divided into group A and group B by lottery method. Out of these, 40 patients have completed the treatment. All 
patients were examined by Wood’s Lamp to assess the depth of pigmentation (Dermal/Epidermal).. It is concluded 
that vyanga is frequent in females than males. It was found in madhyamavastha in which pitta dosha and Rajoguna is 
predominant. Mostly Centrofacial type of melasma is found in this study which is supported by other studies. 
Melasma Severity Index is improved in both the groups. Local application of Ingudi phalmajja is found to be 
effective in the severity of pigmentation. The action of Ingudi phalamajja in hyperpigmentation could not be 
evaluated. Further study can be conducted to find out the active principle of Ingudi. 
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Material and Method 
Source of Material 
The Patients were randomly selected from 
Kayachikitsa OPD of Mahatma Gandhi Ayurved 
College, Hospital & Research center, Salod (H), Wardha 
with the features of Vyanga (Melasma) were selected 
for the study. 
Inclusion criteria 
• Patients of either sex between the age group of 20 - 
50 years. 
• Patients presenting with cardinal features of Vyanga 
are Shyavavarna, Nirujam, Tanu, Mandal (Melasma 
like thin, painless, blackish/brownish patch on facial 
skin). 
Exclusion criteria 
• Cases of drug induced Melasma.  
• Pregnant women 
• Patients with known case of Addison`s disease, 
Cushing’s syndrome or Nelson’s syndrome. 
Investigation 
Before commencement of medication, CBC 
with ESR was done to exclude any infectious condition. 
Methodology 
The patients were selected by simple random 
sampling method irrespective of their sex, religion and 
occupation. The informed consent was obtained from 
each patient before participation in the study. Total 43 
patients were registered as per the inclusion criteria and 
randomly divided into group A and group B by lottery 
method. Out of these, 40 patients have completed the 
treatment. All patients were examined by Wood’s Lamp 
to assess the depth of pigmentation (Dermal/
Epidermal). 
Following treatment was given for both the groups. 
• Group A- Ingudi(Balanites aegyptiaca) phalmajja for 
local application once a day for continuous 90 days.25 
• Group B- Anantamool (Hemidesmus indicus) Ghana 
orally 500 mg twice a day with water after meal and 
local application of Ingudi  phalmajja once a day for 
continuous 90 days.26 
Method of application of Ingudi Phalamajja 
lepa: Patient was advised first to clean the face properly. 
Take the Ingudi phalamajja and rub down with cold 
water on any clean rough surface to make paste in 
sufficient quantity and apply over the affected area for 
20 minutes and then wash the face properly with plain 
water. This lepa was applied once a day for continuous 
90 days. 
Assessment Criteria  
The assessment of patient was done on the basis 
of following MSI score (Melasma severity index) on 
every 30th day. 
Melasma Severity Index score formula 
0.4(a × P2 ) I + 0.4(a × P2 ) r +0.2 (a × P2 ) n 
Where. a – Area, P – Pigmentation, I – Left face , R – 
Right face  
The area involved and severity of pigmentation 
is scored as follows 
Observation & Result 
   The data obtained was coded and entered into Microsoft Excel Worksheet. The data was analyzed by using 
frequency distribution, descriptive statistics, analysis of variance, chi-square test and t-statistic with the help of 
statistical software SPSS 17.0 version and tabulated as below. 
Table No. 1 Gender-wise distribution of Patients 
Table No. 2 Age-wise distribution of Patients 
Grade Area Involvement (A)
0 <10% area involved
1 11-30% area involved
2 31-60% area involved
3 >60% area involved
Grade Pigmentation
0 No visible Pigmentation
1 Barely Visible pigmentation
2 Mild pigmentation
3 Moderate pigmentation
4 Sever pigmentation
Gender
TotalMale Female
Group A 1 (5.0%) 19 (95.0%) 20 (100.0%)
Group B 3 (15.0%) 17 (85.0%) 20 (100.0%)
Total 4 (10.0%) 36 (90.0%) 40 (100.0%)
Age (in years)
Total20-30 31-40 41-50
Group A 2 (10.0%) 13 (65.0%) 5 (25.0%) 20 (100.0%)
Group B 4 (20.0%) 8 (40.0%) 8 (40.0%) 20 (100.0%)
Total 6 (15.0%) 21 (52.5%) 13 (32.5%) 40 (100.0%)
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Table No. 3 Sharir Prakruti of Patients 
Chi-Square Value = 2.667 P Value = 0.446 Non Significant. 
In the categorization of Sharir prakruti, 52.5% patients were of Vata pittaj Prakruti and 35% patients were of 
Pittavataj prakruti. Comparatively less number of patients were of Kapha Pittaj(7.5%)  and  Pitta Kaphaj(5%) 
Prakruti. 
Table No. 4 Manas Prakruti of Patients 
Chi-Square Value = 2.661 P Value = 0.264 Non Significant  In the classification of Manas prakruti, the patients of 
Satvik, Rajasik and Tamasikit Prakruti were 42.5%, 52.5% and 5% respectively. 
Table No. 5  Type of Ahara of Patients in Group A & Group B 
Chi-Square Value = 0.001 P Value = 1.00 Non Significant 
Table No.5 shows that the 55% patients were consuming largely Rajasik ahara and 45% patients were 
consuming mostly Tamasik ahara. 
Table No. 6  Sun Exposure of Patients 
Chi Square = 0.90 P Value = 0.342 Non Significant  Table no. 6 shows that 52.5% patients were having history of 
regular sun exposure and 47.5% patients had no history of frequent sun exposure. 
Table No. 7 Family History of Patients 
Chi-Square Value = 1.616 P Value = 0.204 Non Significant 
Out of 40 patients, 45% patients were having family history of Melasma and 55% patients were not having 
such history. 
Table No. 8 Chronicity wise distribution of Patients 
Chi Square = 1.575 P Value = 0.455 Non Significant 
Analysis of data obtained reveals that majority of the patients (45%) were having chronicity of Vyanga 
between 6months-3years followed by 37%, 17.5% were having 3years- 1year, less than 6 months respectively.  
SharirPrakruti TotalKapha pittaj Pitta kaphaj Pitta Vataj Vataj pittaj
Group A 1 (5.0%) 1 (5.0%) 5 (25.0%) 13 (65.0%) 20 (100.0%)
Group B 2 (10.0%) 1 (5.0%) 9 (45.0%) 8 (40.0%) 20 (100.0%)
Total 3 (7.5%) 2 (5.0%) 14 (35.0%) 21 (52.5%) 40 (100.0%)
Manas Prakruti TotalSatvik Rajasik Tamasik
Group A 6 (30.0%) 13 (65.0%) 1 (5.0%) 20 (100.0%)
Group B 11 (55.0%) 8 (40.0%) 1 (5.0%) 20 (100.0%)
Total 17 (42.5%) 21 (52.5%) 2 (5.0%) 40 (100.0%)
Ahara TotalSatvik Rajasik
Group A 9 (45.0%) 11 (55.0%) 20 (100.0%)
Group B 9 (45.0%) 11 (55.0%) 20 (100.0%)
Total 18 (45.0%) 22 (55.0%) 40 (100.0%)
Sun Exposure TotalYes No
Group A 9 (45.0%) 11 (55.0%) 20 (100.0%)
Group B 12 (60.0%) 8 (40.0%) 20 (100.0%)
Total 21 (52.5%) 19 (47.5%) 40 (100.0%)
Family History TotalYes No
Group A 11 (55.0%) 9 (45.0%) 20 (100.0%)
Group B 7 (35.0%) 13 (65.0%) 20 (100.0%)
Total 18 (45.0%) 22 (55.0%) 40 (100.0%)
Duration Group A Group B Total
Less than 6 months 5 (12.5%) 2 (5.0%) 7 (17.5%)
6months-3 years 8 (20.0%) 10 (25.0%) 18 (45.0%)
3 years-10 years 7 (17.5%) 8 (20.0%) 15 (37.5%)
Total 20 (50.0%) 20 (50.0%) 40 (100.0%)
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Table No. 9 Clinical sub-type wise distribution of Patients 
The Clinical sub-types of Melasma are divided into Centrofacial, Malar and Mandibular. In this study 60% 
and 40% patients were of centrofacial and malar respectively and no mandibular sub type was observed. 
Table No. 10  Dermal/Epidermal classification 
Chi Square = 1.62 P Value = 0.203 Non Significant 
The type of Melasma was diagnosed with the help of Wood’s lamp. It is found that 45% patients were of 
Dermal type and 55% patients were of Epidermal type. 
Table No. 11 Mean MSI Score of Group A 
The MSI score in Group A was 13.74, 10.79, 5.71 and 3.15 on day 0.30th, 60th and 90th respectively. 
Significant difference is observed in the MSI score on 0 day and on 90th day. 
Table No. 12 Mean MSI Score of Group B 
The MSI score in Group B was 17.33, 15.04, 8.65and 8.65on day 0.30th, 60th and 90th respectively. Significant 
difference is observed in the MSI score on 0 day and on 90th day. 
Table No. 13 Comparison of Dermal/Epidermal Melasma in Group A 
Table No. 13 shows the comparison of Dermal and Epidermal type of Melasma in Group A. In Dermal type, 
MSI score was 17.77 on day 0 which was reduced to 5.89 on day 90th.  In Epidermal type, MSI score was 11.57on day 
0 which was reduced to 1.68on day 90th.In both type of Melasma, significant improvement was observed. 
Table No. 14 Comparison of Dermal/Epidermal Melasma in Group B 
Sub-type Group A Group B Total
Centrofacial 10 (25%) 14 (35%) 24 (60%)
Malar 10 (25%) 6 (15.0%) 18 (40%)
Mandibular 0 0 0
Total 20 (50.0%) 20 (50.0%) 40 (100.0%)
Dermal Epidermal Total
Group A 7 (35.0%) 13 (65.0%) 20 (100.0%)
Group B 11 (55.0%) 9 (45.0%) 20 (100.0%)
Total 18 (45.0%) 22 (55.0%) 40 (100.0%)
Group A Mean S.D. Std. Error Mean t-value P value
MSI Score 0 Day 13.74 9.17 2.05
11.391
0.001 
Significant
MSI Score 30th Day 10.79 6.73 1.50
MSI Score 60th Day 5.71 4.21 0.94
MSI Score 90th Day 3.15 3.74 0.83
Group B Mean S.D. Std. Error Mean t-value P value
MSI Score 0 Day 17.33 12.01 2.68
6.263
0.001 
Significant
MSI Score 30th Day 15.04 10.49 2.34
MSI Score 60th Day 8.65 8.20 1.83
MSI Score 90th Day 8.65 7.89 1.76
Group A Mean S.D. Std. Error Mean t-value P Value
Dermal
MSI (Melasma Severity Index)  
SCORE  0 day 17.77 10.60 4.01 2.930 0.026 SignificantMSI (Melasma Severity Index)  
SCORE 3rd  follow up 90th day 5.89 5.18 1.96
Epidermal
MSI (Melasma Severity Index)  
SCORE 0 day 11.57 7.91 2.19 4.793 0.001 SignificantMSI (Melasma Severity Index)  
SCORE 3rd  follow up 90th day 1.68 1.43 0.40
Group B Mean S.D. Std. Error Mean T-value P Value
Dermal
MSI( Melasma Severity Index)  
SCORE  0th day 19.25 13.04 3.93 3.092
0.011 
Significa
ntMSI( Melasma Severity Index)  SCORE 3rd  follow up 90th day 9.07 9.30 2.80
Epidermal
MSI( Melasma Severity Index)  
SCORE 0th day 14.98 10.90 3.63 3.860
0.005 
Significa
ntMSI( Melasma Severity Index)  SCORE 3rd  follow up 90th day 1.20 1.23 0.41
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Table No. 14 shows the comparison of Dermal and Epidermal type of Melasma in Group B. In Dermal type, 
MSI score was 19.25on day 0 which was reduced to 9.07on day 90th. In Epidermal type, MSI score was 14.98on day 0 
which was reduced to 1.20 on day 90th. So in both the types the score was significantly decreased. 
Table No. 15 Comparison of Mean MSI Score in Group A & Group B 
The mean MSI score of group A was 13.74 on day 0 which was decreased to 3.16 on 90th day. In Group B also 
it was decreased from 17.33 to 5.53. In both the groups, MSI score was significantly decreased indicating the 
improvement in hyperpigmentation. 
  
Table no 16 Comparison of Mean MSI Score in Group A & Group B 
Discussion 
Total 43 patients were registered Out of these, 
40 patients have completed the treatment.  In this study, 
90% patients were female. In other studies also the 
percentage of female was predominant(19,20) Females 
are usually utilize different cosmetics. It might be the 
cause of hyperpigmentation.(21,22)  In our study 
Maximum patients were in the age group of 31-40 
years. It is a fertile age group. Use of Oral contraceptive 
pills might be the contributing factor.(23) This study did 
not find significant family history of Melasma. But in 
other studies Family history of melasma was found 
significant.(24) In the classification of Sharirika 
prakriti, most of the patients were of vatapittaja & 
Pittavataj type indicating the role of Pitta & Vata in the 
samprapti of Vyanga. There was no significant 
difference in the number of patients of satvik & rajasik 
prakruti but comparatively the patients of rajasik 
prakruti were more. In Ayurvedic literature, krodha and 
shoka are included in the causative factors of vyanga 
Most of the patients were having diet 
predominant in katu (pungent) & lavan (salty) rasa 
which can be called as rajasik ahar. It might be the 
aggravating factor of Pitta & Vata dosha. In this study, 
52% patients were found to be exposed to sun during 
their working hours but remaining had no direct 
exposure. So it is difficult to make any co-relation 
between sun exposure & Melasma. The patients were 
assessed on the basis of MSI score to evaluate the 
efficacy of trial drugs. The significant improvement was 
found in group A (Ingudi phala majja lepa) and Group 
B (Ingudi phala majja lepa & Anantmool Ghana 
orally). In the comparison of both groups, group B 
showed relatively good score than group A, In both the 
groups, there was significant improvement in Dermal 
and Epidermal types of Melasma.  In literature, 
Anatmool is described as having madhur & tikta Rasa, 
guru & snigdha guna, madhur vipaka & sheet virya. It 
is also described as varnya. All these characteristics 
might be responsible to pacify pitta & Vata which are 
described as root cause of vyanga. Its varnya property 
might be helpful to provide normal color to skin. Ingudi 
is tikta, katu Rasatmaka (predominantly katu rasa) 
having Ushna Virya, Snigdha and Laghu Guna and 
Katu Vipak. It balances Vata and Kapha Dosha of 
Ingudi, it reaches up to the micro channel and liquefies 
the morbid Dosha due to its qualities like ushna and 
tikshna. Because of Snigdha property it protects the skin 
from excessive dryness. It also maintains the normal 
moisture content of the skin, Snigdha Guna is 
responsible for Mardava and Varna Prasadana where 
as Laghu is the property of Agneya Dravya, which in 
turn are responsible for Prabha, Prakasha, and Varna. 
Conclusion 
It is concluded that vyanga is frequent in 
females than males. It was found in madhyamavastha in 
which pitta dosha and Rajoguna is predominant. Only 
sun exposure cannot be called as causative factor 
because it is found in exposed and unexposed both. 
Melasma Severity Index is improved in both the groups. 
Local application of Ingudi phalmajja is found to be 
Mean S.D. t-statistic P value
Group A
0  day 13.74 9.17
5.568 0.001Significant90th day 3.16 3.74
Group B
0  day 17.33 12.01
4.933 0.001Significant90th day 5.53 7.89
MSI score Number of patients Before Treatment Number of patients After treatment 
0-15 24 36
15-30 12 4
30-55 4 0
MSI score Number of patients Before Treatment Number of patients After treatment 
0-10 19 (47.5) 35 (87.5%)
10-20 10 (25%) 02 (5%)
20-30 06 (15%) 03 (7.5%)
30-40 05 (12.5%) 0
335

Shraddha Wake et.al., A study of Ingudi phalamajja Lepa and Ananatmul Ghan in the Management of Vyanga (Melasma)
Published online in http://ijam.co.in ISSN No: 0976-5921
effective in the severity of pigmentation. The action of 
Ingudi phalamajja in hyperpigmentation could not be 
evaluated. Further study can be conducted to find out 
the active principle of Ingudi. 
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